The Erectile Dysfunction Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for Erectile Dysfunction has been experiencing substantial growth over recent years. It is expected to increase from a worth of $2.46 billion in 2024 to an estimated $2.69 billion in 2025. This represents a Compound Annual Growth Rate (CAGR) of 9.2%.
The Erectile Dysfunction Global Market Report predicts the market size will reach $3.78 billion in 2029, with a compound annual growth rate (CAGR) of 8.9%.
Download Your Free Sample of the 2025 Erectile Dysfunction Market Report and Uncover Key Trends Now!The key drivers in the erectile dysfunction market are:
• Rising psychological stress factors contributing to erectile dysfunction
• Increasing incidences of obesity and metabolic disorders
• Growing preference for non-invasive erectile dysfunction treatments
• Increase in patient consultations for sexual health and efforts by governments to promote men’s health.
The erectile dysfunction market covered in this report is segmented –
1) By Product: Drugs, Devices
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Channels
3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Pharmacies, Other End Users
Subsegments:
1) By Drugs: Phosphodiesterase Type 5 (PDE5) Inhibitors, Hormone Therapy, Injectable Medications, Topical Medications
2) By Devices: Vacuum Erection Devices (VEDs), Penile Implants, Shockwave Therapy Devices
The key trends in the erectile dysfunction market are:
• The expansion of e-pharmacies for erectile dysfunction drugs is an emerging trend.
• Advances in penile implant technologies are also shaping the future of the market.
• Technological progress in erectile dysfunction diagnostics is another growing trend.
• The development of innovative treatment methods targeting the root causes of erectile dysfunction signals a noteworthy trend.
Major players in the erectile dysfunction market are:
• Pfizer Inc.
• Bayer AG
• Dong-A Socio Holdings Co. Ltd.
• Sanofi S.A.
• GlaxoSmithKline plc
• Eli Lilly and Company
• Viatris Inc.
• Teva Pharmaceutical Industries Limited
• Boston Scientific Corporation
• Sandoz International GmbH
• Sun Pharmaceutical Industries Limited
• Coloplast Corporation
• Dr. Reddy's Laboratories Limited
• Cipla Limited
• Ferring Pharmaceuticals A/S
• Endo International plc
• Zydus Lifesciences Limited
• Lupin Limited
• Hims & Hers Health Inc.
• Cadila Pharmaceuticals Limited
• VIVUS Inc.
• Rigicon Inc.
• Petros Pharmaceuticals Inc.
• Futura Medical plc
• Apricus Biosciences Inc.
• Pos-T-Vac Medical Inc.
• Initiator Pharma A/S
North America was the largest region in the erectile dysfunction market in 2024